What is the achieved radionuclidic purity level of the extracted Actinium-225?

The radionuclidic purity of the extracted Actinium-225 exceeds 99.99%.

What does NovAccel aim to provide to cancer patients around the world?

NovAccel aims to provide new therapeutic hope to cancer patients worldwide.

NovAccel plans to produce Ac-225 by using a proprietary compact accelerator.

The research and development involve the collaboration of medical and accelerator experts.

The specific radionuclide that was successfully extracted is Actinium-225.

AI News NQ Analysis

NQ Score 0/100

N1 Content Completeness 6

NovAccel has successfully achieved the extraction of Actinium-225 with over 99.99% purity using their proprietary compact accelerator.

Q: What is the achieved radionuclidic purity level of the extracted Actinium-225?: A: The radionuclidic purity of the extracted Actinium-225 exceeds 99.99%.
Q: What does NovAccel aim to provide to cancer patients around the world?: A: NovAccel aims to provide new therapeutic hope to cancer patients worldwide.
Q: How does NovAccel plan to produce the Actinium-225 (Ac-225)?: A: NovAccel plans to produce Ac-225 by using a proprietary compact accelerator.
Q: Whose collaboration is involved in researching and developing the production technology?: A: The research and development involve the collaboration of medical and accelerator experts.
Q: What specific radionuclide was successfully extracted by the project?: A: The specific radionuclide that was successfully extracted is Actinium-225.